QuidelOrtho (QDEL) has a profit margin of -39.2%, below the Healthcare sector average of 14.34%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
The latest profit margin for QDEL is -39.2% as of June 2026. That compares with -16.09% in the prior-year period — down 143.6% year over year. That is below the Healthcare sector average of 14.34%. Investors often review this figure alongside QuidelOrtho's historical trend and sector peers before judging valuation or financial health.
Over the past year, QDEL's profit margin moved from -16.09% to -39.2% — a 143.6% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in QuidelOrtho's valuation or profitability profile.
Against Healthcare companies, QDEL currently prints -39.2% for profit margin, while the sector average sits near 14.34%. That is roughly 373.3% below the sector mean. Large gaps often invite a closer look at QuidelOrtho's growth, margins, and balance sheet.
Profit Margin shows how effectively QuidelOrtho converts resources into returns. At -39.2%, QDEL may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -16.09% in the prior-year period — down 143.6% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting QDEL's profit margin (-39.2%), review year-over-year change from -16.09%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.